Thermo Fisher Spends $925M to Acquire In Vitro Dx Strategy Genetic Engineering News The firm offers HLA typing assays utilizing both serological and molecular technologies, for matching potential donors to recipients, along with tests for the detection of antibodies that can lead to transplant rejection. One Lambda generated revenues ... |
